WHO-led Covax vaccine scheme agrees new supply deal with India's Serum

0:00
play article
Subscribers can listen to this article
Joseph Prezioso / AFP via Getty Images

India's Serum Institute will supply 1.1 billion doses of Covid-19 vaccines developed by AstraZeneca and Novavax to the Covax vaccine scheme as part of a new long-term deal, head of the UN Children's Fund said on Wednesday.

Unicef chief Henrietta Fore said the shots would be delivered over a number of years at the cost of about $3 per dose for low- and middle-income countries.

They would be produced by Serum under a technology transfer agreement, she said in a briefing.

The Covax facility is co-led by GAVI, the World Health Organization, the Coalition for Epidemic Preparedness Innovations and Unicef.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Lockdown For
DAYS
HRS
MINS
Voting Booth
When a Covid-19 vaccine for under 16's becomes available, will you be taking your children to get it?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, immediately!
38% - 3759 votes
I'll wait to see how others respond
26% - 2550 votes
No, I don't think they need it
37% - 3644 votes
Vote
ZAR/USD
15.30
(-1.60)
ZAR/GBP
21.24
(-1.18)
ZAR/EUR
18.31
(-0.77)
ZAR/AUD
11.82
(-1.06)
ZAR/JPY
0.14
(-0.68)
Gold
1697.41
(-0.76)
Silver
25.33
(-2.55)
Platinum
1126.50
(-2.63)
Brent Crude
63.94
(+2.19)
Palladium
2335.00
(+0.34)
All Share
67743.54
(-0.85)
Top 40
62250.03
(-0.97)
Financial 15
12674.59
(+0.82)
Industrial 25
87893.58
(-1.99)
Resource 10
69264.74
(+0.06)
All JSE data delayed by at least 15 minutes morningstar logo